Seeking Alpha

  Acorda Therapeutics, Inc. (ACOR) - NASDAQ

  • Life Sciences Report | Send Message 6 Feb

    Ram Selvaraju: A Pair Of Companies Ride The Sea Change In Cancer Therapeutics $ACOR, $MDVN, $NVS
      ACOR vs. ETF Alternatives
      Company Description
      Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States